NCT04702087View on ClinicalTrials.gov

Omega 3, Leucine, Probiotic Lactobacillus Paracasei PS23 on Muscle Mass in Sarcopenic Subjects

NAUnknownINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

January 30, 2021

Study Completion Date

December 31, 2022

Conditions
SarcopeniaElderlyOmega 3
Interventions
DIETARY_SUPPLEMENT

OLEP

omega 3 (500 mg), leucine (2,5 g), probiotic Lactobacillus paracasei PS23

COMBINATION_PRODUCT

Placebo

Isocaloric formula

Trial Locations (1)

27100

RECRUITING

Azienda di Servizi alla Persona, Pavia

Sponsors

Collaborators (1)

Abiogen Pharma
All Listed Sponsors
collaborator

Abiogen Pharma

INDUSTRY

lead

Azienda di Servizi alla Persona di Pavia

OTHER